For more than 10 years, Bloomberg has been a global leader in health care data in addition to providing market-leading financial data. We aggregate data from over a dozen top health care providers into time-saving tools that help your team — strategists, investor relations, business development — and the executive team make informed strategic decisions.
Download the complete guide to health care data on the Bloomberg Terminal.
Bloomberg has long-standing relationships with data providers and can often offer data at a fraction of the cost compared to individual licenses. In addition, third-party data is supplemented with proprietary research from Bloomberg Intelligence (BI), written by our own team of experienced biotech and pharma, policy and litigation analysts.
BI provides exhaustive, proprietary data sets from BI research. These are combined with third-party sources such as Symphony, Springer and First Data to reveal:
- Clinical trial and drug pipeline data with more than 5,000 private company drug portfolios
- Robust drug-specific event catalyst calendars, prescription and institutional data
- Drug sales and revenue forecasts
- Patent and product liability litigation
Prescription drug data and pricing
Bring together the Wholesale Acquisition Cost (WAC) price of drugs on the U.S. market, both current and historical, with aggregated data feeds from Symphony, First Data Bank, Springer and more, exportable into an API or an Excel file.
Proprietary catalyst calendar
Bloomberg Intelligence’s own catalyst calendar highlights upcoming catalysts and milestones for pipeline drugs and their expected timeline, including FDA advisory meetings, based on company guidance and BI analysis.
With extensive data sets, robust analytics and a team of news and research experts covering the biotech sector, Bloomberg can help health care corporations stay ahead of the curve with the resources to monitor and analyze their own company, industry and competition.
- Monitor news and competitor coverage
- Analysis of pharma company revenues, income sources and patents.
- Search public documents from 1,500+ providers in seconds
- Access to dedicated health care analyst research teams
Supplement the data with research from a dedicated team of biotech and pharma, policy and litigation analysts — averaging more than 15 years of experience — for unparalleled insights on the entire industry. BI analysts are can be contacted at any time through the Bloomberg Terminal to discuss their research.